Donafenib and sintilimab combined with hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma: a prospective, single-arm phase II trial (DoHAICs study)Wei Gao, Wei‐Yang Lu, Wei Zhang et al.|EClinicalMedicine|2025Cited by 9